Zacks Investment Research Upgrades Acasti Pharma (NASDAQ:ACST) to Hold - Defense World

Retrieved on: 2022-04-20 01:48:07

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Acasti Pharma (NASDAQ:ACST) to Hold - Defense World. View article details on HISWAI: https://www.defenseworld.net/2022/04/19/zacks-investment-research-upgrades-acasti-pharma-nasdaqacst-to-hold.html

Excerpt

Renaissance Technologies LLC now owns 69,777 shares of the biopharmaceutical company's stock worth $88,000 after acquiring an additional 26,369 shares ...

Article found on: www.defenseworld.net

View Original Article